|Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis|
L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ...
New England Journal of Medicine 370 (22), 2071-2082, 2014
|Nintedanib in progressive fibrosing interstitial lung diseases|
KR Flaherty, AU Wells, V Cottin, A Devaraj, SLF Walsh, Y Inoue, ...
New England Journal of Medicine 381 (18), 1718-1727, 2019
|Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report|
HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ...
American journal of respiratory and critical care medicine 194 (3), 265-275, 2016
|The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?|
A Moeller, K Ask, D Warburton, J Gauldie, M Kolb
The international journal of biochemistry & cell biology 40 (3), 362-382, 2008
|Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis|
M Kolb, PJ Margetts, DC Anthony, F Pitossi, J Gauldie
The Journal of clinical investigation 107 (12), 1529-1536, 2001
|Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis|
L Wollin, E Wex, A Pautsch, G Schnapp, KE Hostettler, S Stowasser, ...
European Respiratory Journal 45 (5), 1434-1445, 2015
|Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis|
A Moeller, SE Gilpin, K Ask, G Cox, D Cook, J Gauldie, PJ Margetts, ...
American journal of respiratory and critical care medicine 179 (7), 588-594, 2009
|Smad3 null mice develop airspace enlargement and are resistant to TGF-β-mediated pulmonary fibrosis|
P Bonniaud, M Kolb, T Galt, J Robertson, C Robbins, M Stampfli, C Lavery, ...
The Journal of Immunology 173 (3), 2099-2108, 2004
|Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals|
DJ Lederer, SC Bell, RD Branson, JD Chalmers, R Marshall, DM Maslove, ...
Annals of the American Thoracic Society 16 (1), 22-28, 2019
|Proteoglycans decorin and biglycan differentially modulate TGF-β-mediated fibrotic responses in the lung|
M Kolb, PJ Margetts, PJ Sime, J Gauldie
American Journal of Physiology-Lung Cellular and Molecular Physiology 280 (6 …, 2001
|Progressive transforming growth factor β1–induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor|
P Bonniaud, PJ Margetts, M Kolb, JA Schroeder, AM Kapoun, D Damm, ...
American journal of respiratory and critical care medicine 171 (8), 889-898, 2005
|TGF-β and Smad3 signaling link inflammation to chronic fibrogenesis|
P Bonniaud, PJ Margetts, K Ask, K Flanders, J Gauldie, M Kolb
The Journal of Immunology 175 (8), 5390-5395, 2005
|Gene transfer of transforming growth factor-β1 to the rat peritoneum: effects on membrane function|
PJ Margetts, M Kolb, T Galt, CM Hoff, TR Shockley, J Gauldie
Journal of the American Society of Nephrology 12 (10), 2029-2039, 2001
|Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin|
M Kolb, PJ Margetts, T Galt, PJ Sime, Z Xing, M Schmidt, J Gauldie
American journal of respiratory and critical care medicine 163 (3), 770-777, 2001
|Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised …|
AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ...
The lancet Respiratory medicine 8 (5), 453-460, 2020
|Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis|
M Kreuter, S Ehlers-Tenenbaum, K Palmowski, J Bruhwyler, U Oltmanns, ...
PloS one 11 (3), e0151425, 2016
|VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats|
L Farkas, D Farkas, K Ask, A Möller, J Gauldie, P Margetts, M Inman, ...
The Journal of clinical investigation 119 (5), 1298-1311, 2009
|TGF-β, Smad3 and the process of progressive fibrosis|
J Gauldie, P Bonniaud, P Sime, K Ask, M Kolb
Biochemical Society Transactions 35 (4), 661-664, 2007
|Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors|
L Farkas, J Gauldie, NF Voelkel, M Kolb
American journal of respiratory cell and molecular biology 45 (1), 1-15, 2011
|Re-evaluation of fibrogenic cytokines in lung fibrosis|
M Kelly, M Kolb, P Bonniaud, J Gauldie
Current pharmaceutical design 9 (1), 39-49, 2003